Legal & General Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,114	Closed	-$402K	–	2815
2015 Q1	$402K	Buy	4,114 +829	+25%	+$81K	﹤0.01%	1352
2014 Q4	$304K	Sell	3,285 -164	-5%	-$15.2K	﹤0.01%	1375
2014 Q3	$235K	Buy	+3,449	New	+$235K	﹤0.01%	1429